Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Caroline Carbo"'
Autor:
Lauren Etter, Alinani Simukanga, Wenda Qin, Rachel Pieciak, Lawrence Mwananyanda, Margrit Betke, Jackson Phiri, Caroline Carbo, Arnold Hamapa, Chris Gill
Publikováno v:
Gates Open Research, Vol 4 (2020)
Patient identification in low- to middle-income countries is one of the most pressing public health challenges of our day. Given the ubiquity of mobile phones, their use for health-care coupled with a biometric identification method, present a unique
Externí odkaz:
https://doaj.org/article/ff4dd2097be048c4be371eaf7a11c858
Autor:
Lawrence Mwananyanda, Alinani Simukanga, Caroline Carbo, Jackson Phiri, Margrit Betke, Wenda Qin, Lauren Etter, Rachel Pieciak, Christopher J. Gill, Arnold Hamapa
Publikováno v:
Gates Open Research
Patient identification in low- to middle-income countries is one of the most pressing public health challenges of our day. Given the ubiquity of mobile phones, their use for health-care coupled with a biometric identification method, present a unique
Autor:
Mathieu Mateo, Stéphanie Reynard, Natalia Pietrosemoli, Emeline Perthame, Alexandra Journeaux, Kodie Noy, Clara Germain, Xavier Carnec, Caroline Picard, Virginie Borges-Cardoso, Jimmy Hortion, Hélène Lopez-Maestre, Pierrick Regnard, Lyne Fellmann, Audrey Vallve, Stéphane Barron, Ophélie Jourjon, Orianne Lacroix, Aurélie Duthey, Manon Dirheimer, Maïlys Daniau, Catherine Legras-Lachuer, Caroline Carbonnelle, Hervé Raoul, Frédéric Tangy, Sylvain Baize
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-18 (2023)
Lassa virus vaccination is impeded by the limited capacity of vaccine candidates to induce rapid protection. In this study, the authors found that a single shot of a measles-based Lassa vaccine protected nonhuman primates 16 or 8 days after vaccinati
Externí odkaz:
https://doaj.org/article/cf6be5bf89674509b73202e1f94537d5
Autor:
Mathieu Mateo, Jimmy Hortion, Emeline Perthame, Caroline Picard, Stéphanie Reynard, Alexandra Journeaux, Clara Germain, Xavier Carnec, Nicolas Baillet, Virginie Borges-Cardoso, Natalia Pietrosemoli, Audrey Vallve, Stéphane Barron, Ophélie Jourjon, Orianne Lacroix, Aurélie Duthey, Manon Dirheimer, Maïlys Daniau, Catherine Legras-Lachuer, Gregory Jouvion, Caroline Carbonnelle, Hervé Raoul, Sylvain Baize
Publikováno v:
Virulence, Vol 13, Iss 1, Pp 654-669 (2022)
The area of Lassa virus (LASV) circulation is expanding, with the emergence of highly pathogenic new LASV lineages. Benin recently became an endemic country for LASV and has seen the emergence of a new LASV lineage (VII). The first two outbreaks in 2
Externí odkaz:
https://doaj.org/article/c350a40e14234312b45ff573b2fd8f25
Autor:
François Enchéry, Claire Dumont, Mathieu Iampietro, Rodolphe Pelissier, Noémie Aurine, Louis-Marie Bloyet, Caroline Carbonnelle, Cyrille Mathieu, Chloé Journo, Denis Gerlier, Branka Horvat
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-15 (2021)
In a study using both human cells and the African green monkeys, Enchery et al report that the highly pathogenic bat-borne Nipah virus (NiV), inhibits the NF-κB pathway via its nonstructural W protein. They demonstrate that it exerts this effect by
Externí odkaz:
https://doaj.org/article/dc79959663c145a4baf6f7ace28e5108
Autor:
Nicolas Baillet, Stéphanie Reynard, Emeline Perthame, Jimmy Hortion, Alexandra Journeaux, Mathieu Mateo, Xavier Carnec, Justine Schaeffer, Caroline Picard, Laura Barrot, Stéphane Barron, Audrey Vallve, Aurélie Duthey, Frédéric Jacquot, Cathy Boehringer, Grégory Jouvion, Natalia Pietrosemoli, Rachel Legendre, Marie-Agnès Dillies, Richard Allan, Catherine Legras-Lachuer, Caroline Carbonnelle, Hervé Raoul, Sylvain Baize
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-19 (2021)
Baillet et al. use the cynomolgus monkey model to model Lassa virus and associated Lassa fever (LF). They provide a full characterisation of LF pathogenesis with the aim of assisting the development of early diagnostic tools.
Externí odkaz:
https://doaj.org/article/97528d0810d148d594a62a4f23cbd59b
Autor:
Caroline Carbonnelle, Marie Moroso, Delphine Pannetier, Sabine Godard, Stéphane Mély, Damien Thomas, Aurélie Duthey, Ophélie Jourjon, Orianne Lacroix, Béatrice Labrosse, Hervé Raoul, Karen L. Osman, Francisco J. Salguero, Yper Hall, Carol L. Sabourin, Michael J. Merchlinsky, James P. Long, Lindsay A. Parish, Daniel N. Wolfe
Publikováno v:
Vaccines, Vol 10, Iss 6, p 963 (2022)
Sudan ebolavirus (SUDV) is one of four members of the Ebolavirus genus known to cause Ebola Virus Disease (EVD) in humans, which is characterized by hemorrhagic fever and a high case fatality rate. While licensed therapeutics and vaccines are availab
Externí odkaz:
https://doaj.org/article/1816bfa814204221a31360efa99236d1
Autor:
Vincent Madelain, Sylvain Baize, Frédéric Jacquot, Stéphanie Reynard, Alexandra Fizet, Stephane Barron, Caroline Solas, Bruno Lacarelle, Caroline Carbonnelle, France Mentré, Hervé Raoul, Xavier de Lamballerie, Jérémie Guedj
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Optimization of antiviral therapy can be crucial in the management of Ebola virus outbreaks. Here, Madelain et al. use an integrative mathematical model to correlate the dose and the time of treatment initiation with survival rate, enhanced immune re
Externí odkaz:
https://doaj.org/article/8007c9d9b043441c879ab95a1e9f13f9
Autor:
Stuart D. Dowall, Frédéric Jacquot, John Landon, Emma Rayner, Graham Hall, Caroline Carbonnelle, Hervé Raoul, Delphine Pannetier, Ian Cameron, Ruth Coxon, Ibrahim Al Abdulla, Roger Hewson, Miles W. Carroll
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-15 (2017)
Abstract Despite sporadic outbreaks of Ebola virus (EBOV) over the last 4 decades and the recent public health emergency in West Africa, there are still no approved vaccines or therapeutics for the treatment of acute EBOV disease (EVD). In response t
Externí odkaz:
https://doaj.org/article/7b63ac3978a941a387227fe5cf54b86d
Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.
Autor:
Jérémie Guedj, Géraldine Piorkowski, Frédéric Jacquot, Vincent Madelain, Thi Huyen Tram Nguyen, Anne Rodallec, Stephan Gunther, Caroline Carbonnelle, France Mentré, Hervé Raoul, Xavier de Lamballerie
Publikováno v:
PLoS Medicine, Vol 15, Iss 3, p e1002535 (2018)
BackgroundDespite repeated outbreaks, in particular the devastating 2014-2016 epidemic, there is no effective treatment validated for patients with Ebola virus disease (EVD). Among the drug candidates is the broad-spectrum polymerase inhibitor favipi
Externí odkaz:
https://doaj.org/article/147194498faa4e8586598c051a408aa6